These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8252591)

  • 1. Ventricular adenine nucleotide translocator mRNA is upregulated in dilated cardiomyopathy.
    Sylvén C; Lin L; Jansson E; Sotonyi P; Fu LX; Waagstein F; Hjalmarsson A; Marcus C; Brönnegård M
    Cardiovasc Res; 1993 Jul; 27(7):1295-9. PubMed ID: 8252591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The myocardial expression of the adenine nucleotide translocator isoforms is specifically altered in dilated cardiomyopathy.
    Dörner A; Schultheiss HP
    Herz; 2000 May; 25(3):176-80. PubMed ID: 10904836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial mRNA content and stability, and enzyme activities of Ca-cycling and aerobic metabolism in canine dilated cardiomyopathies.
    O'Brien PJ; Duke AL; Shen H; Shohet RV
    Mol Cell Biochem; 1995 Jan; 142(2):139-50. PubMed ID: 7770066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysfunction of the ADP/ATP carrier as a causative factor for the disturbance of the myocardial energy metabolism in dilated cardiomyopathy.
    Schultheiss HP
    Basic Res Cardiol; 1992; 87 Suppl 1():311-20. PubMed ID: 1497575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta 1 and beta 2 adrenoceptor ligand and mRNA expression in dilated cardiomyopathy.
    Sylvén C; Mischa G; Jansson E; Sotonyi P; Fu LX; Waagstein F; Brönnegård M
    Biol Pharm Bull; 1995 Oct; 18(10):1430-4. PubMed ID: 8593450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenine nucleotide translocator in heart.
    Portman MA
    Mol Genet Metab; 2000; 71(1-2):445-50. PubMed ID: 11001838
    [No Abstract]   [Full Text] [Related]  

  • 7. Myocardial enzyme activities in patients with mitral regurgitation or mitral stenosis.
    Jansson E; Sylvén C; Henze A; Kaijser L
    Cardiovasc Res; 1987 Mar; 21(3):202-7. PubMed ID: 3652086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenine nucleotide translocase 1 deficiency results in dilated cardiomyopathy with defects in myocardial mechanics, histopathological alterations, and activation of apoptosis.
    Narula N; Zaragoza MV; Sengupta PP; Li P; Haider N; Verjans J; Waymire K; Vannan M; Wallace DC
    JACC Cardiovasc Imaging; 2011 Jan; 4(1):1-10. PubMed ID: 21232697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Energetics and function of the failing human heart with dilated or hypertrophic cardiomyopathy.
    Kalsi KK; Smolenski RT; Pritchard RD; Khaghani A; Seymour AM; Yacoub MH
    Eur J Clin Invest; 1999 Jun; 29(6):469-77. PubMed ID: 10354207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key enzymes of myocardial energy metabolism in papillary muscle of patients with mitral valve disease--relation to left ventricular function.
    Sylvén C; Jansson E; Szamosi A; Böök K
    Scand J Thorac Cardiovasc Surg; 1989; 23(1):63-7. PubMed ID: 2524875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of the lactate dehydrogenase M subunit in myocardial regions with decreased thallium uptake.
    Lin L; Kaijser L; Liska J; Sylvén C; Holmgren A; Lindström K; Jansson E
    Cardiovasc Res; 1993 Jul; 27(7):1300-5. PubMed ID: 8252592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Na,K-ATPase receptor subunits alpha 1, alpha 2 and alpha 3 mRNA in dilated cardiomyopathy.
    Sylvén C; Jansson E; Sotonyi P; Waagstein F; Brönnegård M
    Biol Pharm Bull; 1995 Jun; 18(6):907-9. PubMed ID: 7550131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Key enzymes of myocardial energy metabolism in patients with valvular heart disease: relation to left ventricular function.
    Sylvén C; Jansson E; Böök K
    Acta Physiol Scand; 1988 Mar; 132(3):267-70. PubMed ID: 2976229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coenzyme Q10 and key enzyme activities in papillary muscle related to left ventricle function in mitral valve disease.
    Karlsson J; Sylvén C; Jansson E; Böök K; Muratsu K; Folkers K
    Mol Cell Biochem; 1988 Nov; 84(1):59-64. PubMed ID: 3231216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of creatine kinase shuttle enzymes in the human heart.
    Sylvén C; Lin L; Kallner A; Sotonyi P; Somogyi E; Jansson E
    Eur J Clin Invest; 1991 Jun; 21(3):350-4. PubMed ID: 1909638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional biochemical remodeling in non-infarcted tissue of rat heart post-myocardial infarction.
    Laser A; Ingwall JS; Tian R; Reis I; Hu K; Gaudron P; Ertl G; Neubauer S
    J Mol Cell Cardiol; 1996 Jul; 28(7):1531-8. PubMed ID: 8841940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of myocardial enzyme activities of the energy-supplying metabolism in patients with dilative cardiomyopathies and valve diseases.
    Klein HH; Spaar U; Schlepple H; Wiegand V; Kreuzer H
    Clin Cardiol; 1986 May; 9(5):197-202. PubMed ID: 3708946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between alcohol intake, myocardial enzyme activity, and myocardial function in dilated cardiomyopathy. Evidence for the concept of alcohol induced heart muscle disease.
    Richardson PJ; Wodak AD; Atkinson L; Saunders JB; Jewitt DE
    Br Heart J; 1986 Aug; 56(2):165-70. PubMed ID: 3730217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitral valve surgery for mitral regurgitation in patients with advanced dilated cardiomyopathy.
    Gatti G; Cardu G; Pugliese P
    Ital Heart J; 2003 Jan; 4(1):29-34. PubMed ID: 12690918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical ventricular restoration combined with mitral valve procedure for endstage ischemic cardiomyopathy.
    Suma H; Tanabe H; Uejima T; Isomura T; Horii T
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):280-4; discussion 284-5. PubMed ID: 19394851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.